About Michael Bozik
Michael Bozik is an executive officer and director of Telemachus Therapeutics, Inc. The company is a Delaware pharmaceutical startup incorporated in 2026. It plans to pair therapeutic research with cloud-based analysis of research data. Bozik is the contact for company and partnership inquiries.
Experience
This experience comes from official bios, from Michael Bozik's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Bozik in the role, so the role may have started earlier or lasted longer.
Telemachus Therapeutics, Inc. Current
Executive Officer & Director
2026 – Present · Wexford, PA
A pharmaceutical startup that plans to keep context and limits attached to research data used in therapeutic decisions.
BP
Biohaven Pharmaceuticals Current
President, Ion Channel Research and Development
2022 – Present
AR
AreteiaTx Current
Member Board Of Directors
2022 – Present
LP
Life Sciences Pennsylvania
Member Board of Directors
2018 – 2024
KL
Knopp Biosciences LLC
President and CEO
2005 – 2022
BS
Bristol-Myers Squibb
VP, Neuroscience Development
1998 – 2004
UI
UNIVERSITY OF PITTSBURGH CANCER INSTITUTE
Co-Director, Brain Tumor Center
1996 – 1998
UM
University of Pittsburgh School of Medicine
Chief, Division of Neuro-oncology
1994 – 1998
Key Colleagues at Startups
The people Michael Bozik works with at each company, as listed on that company's latest Form D.
Telemachus Therapeutics, Inc. · Form D/A, Oct 28, 2026
GH
Gregory Hebrank
Executive Officer & Director
Areteia Therapeutics, Inc. · Form D/A, Feb 21, 2025
BG
Benjamin Gomez
Director
AK
Adam Koppel
Director
IR
Ian Read
Director
DB
Daniel Becker
Director
RW
Robin Walker
Executive officer
PB
Paul Berns
Director
CC
Christopher Courts
Executive officer
SB
Stephen Butts
Director
JB
Jorge Bartolome
Chief Executive Officer and director
ES
Elyse Stock
Director